Insulin and Cancer

The series of articles brings up all sorts of questions: Do other newer long-acting insulin analogs such as Levemir (insulin detemir) also share this association? If Lantus is associated with cancer, what kind of cancer? Does the administration of insulin cause a new cancer, or cause a pre-existing cancer to grow faster than if there had been no insulin therapy? None of these questions are answered in the studies that are published here.

Submitted by Avera

• 99 Views
• 0 Comments

Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels Of Patients With Type 2 Diabetes In TITRATE(R) Study

Novo Nordisk announced results from the TITRATE® study showing that Levemir® (insulin detemir [rDNA origin] injection), taken once-daily, substantially lowered average blood sugar. Type 2 diabetes patients took a more active role in their treatment by adjusting their own dosing, after being trained and given an adjustment schedule by their physician. Approximately 60 percent of patients taking Levemir® once-daily reached the American Diabetes Association's (ADA) recommended average blood sugar level.

Submitted by Avera

• 47 Views
• 0 Comments

Novo Nordisk Launches Levemir(R) Satisfaction Guarantee Program

Patients with type 2 diabetes face many challenges, including blood sugar monitoring, maintaining a healthy diet and transitioning to new therapies. Novo Nordisk (NYSE: NVO), the world's largest maker of insulin, is committed to helping new patients make the move to insulin. As part of that commitment, the company is announcing its Levemir® Satisfaction Guarantee for U.S. patients taking Levemir® (insulin detemir [rDNA origin] injection) to treat type 2 diabetes.

First-time insulin users have... read more

Submitted by Avera

• 123 Views
• 0 Comments